Media Room
latest news
AMR Industry Alliance Round-Up, Issue No.2, September 2019
Welcome to the second issue of the Alliance Round-Up – written for more than 100 biotech, diagnostic, generic and R&D pharma companies that are members of the AMR Industry Alliance, as well as...
Read more
New brochure to discover the AMR Industry Alliance in 2 minutes
Representing more than 100 biotechnology, diagnostics, generics and research-based pharmaceutical companies and associations, the AMR Industry Alliance is one of the largest private sector coalitions...
Read more
AMR Industry Alliance Round-Up, Issue No.1, June 2019
This is the first issue of "Alliance Round-Up" written for the more than 100 biotech, diagnostic, generic and pharma companies who are members of the AMR Industry Alliance, as well as people...
Read morefrom the blog
The new reality for next-gen antibiotics
The future of antibiotic development lies in targeted approaches that can deliver novel drugs tailored to tackle those highly resistant pathogens with greatest medical need. The world of antibacte...
Read more
Putting the brakes on AMR in India
India’s ban on colistin in the animal food industry marks a critical move against AMR in the country; one that should go hand in hand with a stringent crackdown on inappropriate use in human medicin...
Read more
Overcoming Access Barriers to Antibiotics
Somewhat perversely, antibiotic overuse exists side-by-side with lack of access to such medicines in today’s world. While we are aware of the consequences of drug-resistant bacterial infections, it...
Read morein the press
Pharmaceuticals in the Environment
This article was published on PharmTech on 2 August, 2018 (Pharmaceutical Technology, Volume 42, Issue 8). Content by Sean Milmo. "An Antimicrobial Resistance (AMR) Industry Allian...
Read more
Antimicrobial resistance and vaccines – Life science industry makes the link and drives progress
This Q&A was first published on PharmExec on 20 April, 2018. Interview by Julian Upton. 1. When trying to reduce antimicrobial resistance, how can vaccines help? Vaccines are critical and po...
Read more
NZZ – We need a sustainable business model
This interview was first published on NZZ on 24 February 2018. Interview by Birgit Voigt. NZZ on Sunday: Why is the pharmaceutical industry not developing more new antibiotics? Thomas Cueni: Today...
Read more